Navigation Links
Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
Date:7/25/2013

0.17)$(2.42)Weighted-average shares outstandingBasic

1,343.51,423.21,347.71,434.2Assuming dilution

1,358.61,423.21,347.71,434.2 

 

 

 

BOSTON SCIENTIFIC CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS

 As ofJune 30, December 31,in millions, except share data20132012(Unaudited)ASSETSCurrent assets:Cash and cash equivalents

$

530$

207Trade accounts receivable, net

1,2781,217Inventories

842884Deferred income taxes

496433Prepaid expenses and other current assets

352281Total current assets

3,4983,022Property, plant and equipment, net

1,5241,564Goodwill

5,5535,973Other intangible assets, net

6,0266,289Other long-term assets

395306$16,996$17,154LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Current debt obligations

$

605$

4Accounts payable

251232Accrued expenses

1,3651,284Other current liabilities

256252Total current liabilities

2,4771,772Long-term debt

3,6474,252Deferred income taxes

1,7111,713Other long-term liabilities

2,5582,547Commitments and contingenciesStockholders' equityPreferred stock, $.01 par value - authorized 50,000,000shares, none issued and outstandingCommon stock, $.01 par value - authorized 2,000,000,000shares and issued 1,551,642,655 shares as of June 30,2013 and 1,542,347,188 shares as of December 31, 2012

1615Treasury stock, at cost 212,293,891 shares as of June 30, 2013and 186,635,532 shares as of December 31, 2012

(1,292)(1,092)Additional paid-in capital

16,47016,429Accumulated deficit

(8,673)(8,449)Accumulated other comprehensive income (loss), net of tax

82(33)Total stockholders' equity

6,6036,870$16,996$17,154 

 

 

 

BOSTON SCIENTIFIC CORPORATIONNON-GAA
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. American Laboratory Trading Continues Steady Growth with Expansion in Boston
2. Affordable Scrum Training in Boston,MA by Conscires Agile Practices
3. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
4. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
7. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
8. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
9. Boston College researchers unique nanostructure produces novel plasmonic halos
10. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
11. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... company focused on the development of autologous cell ... the International Society for Cellular Therapy (ISCT) on ... currently in a Phase 1/2 clinical trial.  The ... from 5:30 PM to 7:00 PM local time, ...
(Date:5/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has ... HW_Technical Insights" report to their offering. ... in the Health and Wellness sector and has identified ... impact in the year 2015. The research service provides ... and wellness technologies that are anticipated to have the ...
(Date:5/20/2015)... The global genotyping market is expected to ... period of 2015 to 2020 to reach $17.0billion in ... discovery and development process and to provide personalized therapy, ... this,heavy investments by key manufacturers to offer advanced and ... growth. Browse 113 market data tables & 37 figures ...
(Date:5/20/2015)... Mass. , May 20, 2015  Haemonetics Corporation ... Concannon , President & CEO, will present at The ... York on June 1 st , 2015 ... may access Mr. Concannon,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Top Technologies in the Health and Wellness Industry 2015 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5
... Market Expenditures for MRSA ... $80 Million by 2012, SUNNYVALE, Calif., Jan. 29 ... issued a medical device,license for the Xpert(TM) MRSA test ... on nasal swabs and the GeneXpert(R),System. Xpert MRSA test ...
... OXFORD, England, January 29 Circassia Ltd, ... system responses,announced today that it has successfully ... second round funding. The investment,syndicate includes new ... as existing investors, including Imperial Innovations and ...
... NanoJapan, a unique, Rice University-based program that combines ... a targeted undergraduate research internship in nanotechnology, has ... prestigious Andrew Heiskell Award for Innovation in International ... to promote and honor the most outstanding initiatives ...
Cached Biology Technology:Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding 2Rice wins innovation award for international program 2
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... a protein in the brain that plays a key role ... cell that supplies energy, supports cellular activity, and potentially wards ... today in the Journal of Cell Biology , may ... "Understanding the molecular machinery that helps distribute ...
... Australian and New Zealand researchers have accelerated research ... genes which will help to unravel the causes of ... findings will be published today in the prestigious journal ... of MS has remained a mystery. This discovery reveals ...
... College of Medicine have discovered how the mutated huntingtin gene ... Huntington,s disease. The report of their findings is available in ... to show that the mutated huntingtin gene activates a particular ... further, to show what effect activation of that enzyme has ...
Cached Biology News:Protein regulates movement of mitochondria in brain cells 2Protein regulates movement of mitochondria in brain cells 3Aussie and Kiwi researchers make double MS genetic discovery 2Huntington's disease deciphered 2Huntington's disease deciphered 3
... has been designed and created in order ... friendly genotyping analysis tool. We incorporated the ... into the software. Their main requirements were ... low acquisition cost. GeneMarker can perform ...
... through columns is a well-known separation technique ... applications are in DNA/RNA extraction in microbiology, ... purification in chemical or analytical laboratories. ... Genesis series instruments for smaller scales. The ...
... structure visualization, phylogenetic tree building, sequence analysis, ... application. Retrieve sequences ... filter them in real-time Organize your ... filtering and sorting Provides up-to-date articles ...
Transfection Buffer A & B Set 5 ml each...
Biology Products: